Sumoylation-dependent Control of Homotypic and Heterotypic Synergy by the Krüppel-type Zinc Finger Protein ZBP-89*
暂无分享,去创建一个
[1] J. Merchant,et al. The human ZBP-89 homolog, located at Chromosome 3q21, represses gastrin gene expression , 1998, Mammalian Genome.
[2] Z. Zehner,et al. The zinc finger repressor, ZBP‐89, recruits histone deacetylase 1 to repress vimentin gene expression , 2007, Genes to cells : devoted to molecular & cellular mechanisms.
[3] Stefani N. Thomas,et al. Doxorubicin Down-regulates Krüppel-associated Box Domain-associated Protein 1 Sumoylation That Relieves Its Transcription Repression on p21WAF1/CIP1 in Breast Cancer MCF-7 Cells* , 2007, Journal of Biological Chemistry.
[4] Ming-Jing Hwang,et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. , 2006, Molecular cell.
[5] E. Lam,et al. Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone , 2006, Proceedings of the National Academy of Sciences.
[6] J. Merchant,et al. Intestinal overexpression of ZNF148 suppresses ApcMin/+ neoplasia , 2006, Mammalian Genome.
[7] C. Shelley,et al. The transcription factor ZBP-89 controls generation of the hematopoietic lineage in zebrafish and mouse embryonic stem cells , 2006, Development.
[8] Alison M. Urvalek,et al. Sumoylation Delimits KLF8 Transcriptional Activity Associated with the Cell Cycle Regulation* , 2006, Journal of Biological Chemistry.
[9] E. Yeh,et al. Characterization of a Family of Nucleolar SUMO-specific Proteases with Preference for SUMO-2 or SUMO-3* , 2006, Journal of Biological Chemistry.
[10] E. Kieff,et al. NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Brattain,et al. Sumoylation Inhibits Cleavage of Sp1 N-terminal Negative Regulatory Domain and Inhibits Sp1-dependent Transcription* , 2006, Journal of Biological Chemistry.
[12] J. Merchant,et al. An isoform of ZBP-89 predisposes the colon to colitis , 2006, Nucleic acids research.
[13] David Owerbach,et al. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. , 2005, Biochemical and biophysical research communications.
[14] H. Cohen,et al. Glucocorticoids Regulate Transcription of the Gene for Phosphoenolpyruvate Carboxykinase in the Liver via an Extended Glucocorticoid Regulatory Unit* , 2005, Journal of Biological Chemistry.
[15] David Reverter,et al. Insights into E3 ligase activity revealed by a SUMO–RanGAP1–Ubc9–Nup358 complex , 2005, Nature.
[16] J. Iñiguez-Lluhí,et al. A Small Conserved Surface in SUMO Is the Critical Structural Determinant of Its Transcriptional Inhibitory Properties , 2005, Molecular and Cellular Biology.
[17] R. Hay,et al. SUMO: a history of modification. , 2005, Molecular cell.
[18] G. Goubin,et al. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo , 2005, Molecular and Cellular Biochemistry.
[19] T. A. Wilkinson,et al. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Shirakawa,et al. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. , 2004, Molecular endocrinology.
[21] M. Atchison,et al. Regulation of Murine Cytochrome c Oxidase Vb Gene Expression during Myogenesis , 2004, Journal of Biological Chemistry.
[22] D. Granner,et al. The Synergistic Effect of Dexamethasone and All-trans-retinoic Acid on Hepatic Phosphoenolpyruvate Carboxykinase Gene Expression Involves the Coactivator p300* , 2004, Journal of Biological Chemistry.
[23] K. Bohren,et al. A M55V Polymorphism in a Novel SUMO Gene (SUMO-4) Differentially Activates Heat Shock Transcription Factors and Is Associated with Susceptibility to Type I Diabetes Mellitus* , 2004, Journal of Biological Chemistry.
[24] Erica S. Johnson,et al. Protein modification by SUMO. , 2004, Annual review of biochemistry.
[25] A. Sharrocks,et al. SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.
[26] J. Merchant,et al. Transcription factor ZBP-89 is required for STAT1 constitutive expression. , 2003, Nucleic acids research.
[27] J. Iñiguez-Lluhí,et al. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] K. Nakao,et al. Modification of GATA‐2 Transcriptional Activity in Endothelial Cells by the SUMO E3 Ligase PIASy , 2003, Circulation research.
[29] Z. Zehner,et al. ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. , 2003, Nucleic acids research.
[30] C. Shelley,et al. The zinc finger transcription factor ZBP-89 is a repressor of the human beta 2-integrin CD11b gene. , 2003, Blood.
[31] Y. Mishina,et al. Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis , 2003, Nature Genetics.
[32] J. Iñiguez-Lluhí,et al. A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3* , 2003, The Journal of Biological Chemistry.
[33] F. Melchior,et al. Transcription factor Sp3 is silenced through SUMO modification by PIAS1 , 2002, The EMBO journal.
[34] L. Zon,et al. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. , 2002, Molecular cell.
[35] H. Su,et al. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. , 2002, Gene.
[36] A. Dejean,et al. The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.
[37] L. Bruhn,et al. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. , 2001, Genes & development.
[38] J. Merchant,et al. ZBP-89 Promotes Growth Arrest through Stabilization of p53 , 2001, Molecular and Cellular Biology.
[39] R. Perlmutter,et al. Identification and Characterization of a Transcriptional Regulator for the lck Proximal Promoter* , 2001, The Journal of Biological Chemistry.
[40] J. Palvimo,et al. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[41] Hirofumi Tanaka,et al. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. , 2000, European journal of biochemistry.
[42] J. Merchant,et al. Transcription Factor ZBP-89 Cooperates with Histone Acetyltransferase p300 during Butyrate Activation of p21 waf1 Transcription in Human Cells* , 2000, The Journal of Biological Chemistry.
[43] J. Iñiguez-Lluhí,et al. A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.
[44] E. Yeh,et al. Ubiquitin-like proteins: new wines in new bottles. , 2000, Gene.
[45] Z. Zehner,et al. The Zinc Finger Repressor, ZBP-89, Binds to the Silencer Element of the Human Vimentin Gene and Complexes with the Transcriptional Activator, Sp1* , 2000, The Journal of Biological Chemistry.
[46] M. Waterman,et al. Three zinc finger nuclear proteins, Sp1, Sp3, and a ZBP-89 homologue, bind to the cyclic adenosine monophosphate-responsive sequence of the bovine adrenodoxin gene and regulate transcription. , 2000, Biochemistry.
[47] H. Saitoh,et al. Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.
[48] A. Henney,et al. Human stromelysin gene promoter activity is modulated by transcription factor ZBP‐89 , 1999, FEBS letters.
[49] G. Mize,et al. Transcription Factor ZBP-89 Regulates the Activity of the Ornithine Decarboxylase Promoter* , 1998, The Journal of Biological Chemistry.
[50] G. Barbieri,et al. Negative Regulation of β Enolase Gene Transcription in Embryonic Muscle Is Dependent upon a Zinc Finger Factor That Binds to the G-rich Box within the Muscle-specific Enhancer* , 1998, The Journal of Biological Chemistry.
[51] B. de Crombrugghe,et al. Cloning and Characterization of a Transcription Factor That Binds to the Proximal Promoters of the Two Mouse Type I Collagen Genes* , 1997, The Journal of Biological Chemistry.
[52] K. Yamamoto,et al. Three Amino Acid Substitutions Selectively Disrupt the Activation but Not the Repression Function of the Glucocorticoid Receptor N Terminus* , 1997, The Journal of Biological Chemistry.
[53] R. Bassel-Duby,et al. ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter , 1996, Molecular and cellular biology.
[54] C. Kaltschmidt,et al. Multiple domains of the glucocorticoid receptor involved in synergism with the CACCC box factor(s). , 1991, Molecular endocrinology.
[55] R. Tjian,et al. Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.
[56] G. Schütz,et al. Synergistic action of the glucocorticoid receptor with transcription factors. , 1988, The EMBO journal.
[57] B. Gloss,et al. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene , 1987, Cell.